Trial Profile
A phase 2 pivotal trial of AB-SA01 to treat patients with Staphylococcal-infections
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2017
Price :
$35
*
At a glance
- Drugs AP SA01 (Primary)
- Indications Staphylococcal infections
- Focus Registrational; Therapeutic Use
- Sponsors AmpliPhi Biosciences Corporation
- 21 Dec 2017 New trial record
- 14 Dec 2017 According to an AmpliPhi Biosciences media release, company plans to initiate the clinical trial in second half of 2018.